Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI) earnings
MRVI earnings moved a median of +1.38% by the close. Quarterly and annual MRVI reports and results, each read against the price at its own news timestamp. Back to the MRVI overview →
31 measured MRVI earnings events.
Where these MRVI earnings landedvs 27 measured MRVI earnings reactions
| Middle 50% of MRVI earnings reactions | -1.31% to +6.29% |
|---|---|
| Median reaction (to close) | +1.38% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 MRVI earnings events with a measured close landed between -1.31% and +6.29%; 59% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q MARAVAI LIFESCIENCES For: Sep 30 | SEC filing · Form 10-Q | +1.57% | +7.12% | |
| Maravai LifeSciences Reports Third Quarter 2026 Financial Results | Press release | +6.25% | +2.65% | |
| Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 4, 2026 | Press release | -1.64% | +5.52% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | +3.31% | — | |
| Maravai LifeSciences Reports Second Quarter 2026 Financial Results | Press release | +3.13% | +14.73% | |
| Maravai LifeSciences To Host Earnings Conference Call on Thursday, August 6, 2026 | Press release | +2.54% | -0.56% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | +1.45% | -2.07% | |
| Maravai LifeSciences Reports First Quarter 2026 Financial Results | Press release | +4.82% | +11.24% | |
| Maravai LifeSciences To Host Earnings Conference Call on Thursday, May 7, 2026 | Press release | -1.79% | +1.38% | |
| Form 10-K MARAVAI LIFESCIENCES For: Dec 31 | SEC filing · Form 10-K | +0.85% | +0.85% | |
| Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026 | Press release | +3.21% | +0.32% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Sep 30 | SEC filing · Form 10-Q | +1.20% | +6.16% | |
| Maravai LifeSciences Reports Third Quarter 2025 Financial Results | Press release | +7.75% | +11.24% | |
| Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025 | Press release | +0.88% | +1.46% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | +7.72% | — | |
| Maravai LifeSciences Reports Second Quarter 2025 Financial Results | Press release | +7.72% | — | |
| Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 | Press release | -1.13% | — | |
| Form 10-Q MARAVAI LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | +6.60% | -2.83% | |
| Maravai Lifesciences Reports First Quarter 2025 Financial Results | Press release | +6.60% | -2.83% | |
| Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025 | Press release | -3.19% | -0.49% | |
| Form 10-K MARAVAI LIFESCIENCES For: Dec 31 | SEC filing · Form 10-K | -8.14% | -5.81% | |
| Form NT 10-K MARAVAI LIFESCIENCES For: Mar 04 | SEC filing · Form NT | -1.78% | +0.00% | |
| Maravai LifeSciences Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call | Press release | -2.06% | -7.65% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Sep 30 | SEC filing · Form 10-Q | -4.43% | -10.92% | |
| Maravai LifeSciences Reports Third Quarter 2024 Financial Results | Press release | +1.16% | +6.84% | |
| Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 7, 2024 | Press release | -1.56% | -0.48% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Jun 30 | SEC filing · Form 10-Q | +0.68% | -2.62% | |
| Maravai LifeSciences Reports Second Quarter 2024 Financial Results | Press release | -8.55% | +3.48% | |
| Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024 | Press release | -1.45% | +1.45% | |
| Form 10-Q MARAVAI LIFESCIENCES For: Mar 31 | SEC filing · Form 10-Q | +4.07% | +6.41% | |
| Maravai LifeSciences Reports First Quarter 2024 Financial Results | Press release | +3.50% | +7.76% |
Keep exploring
More MRVI: analyst actions → · SEC filings → · MRVI overview →